These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 34065168)

  • 1. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.
    López-Gambero AJ; Rosell-Valle C; Medina-Vera D; Navarro JA; Vargas A; Rivera P; Sanjuan C; Rodríguez de Fonseca F; Suárez J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer's disease.
    López-Gambero AJ; Pacheco-Sánchez B; Rosell-Valle C; Medina-Vera D; Navarro JA; Fernández-Arjona MDM; de Ceglia M; Sanjuan C; Simon V; Cota D; Rivera P; Rodríguez de Fonseca F; Suárez J
    Biomed Pharmacother; 2022 Jun; 150():112994. PubMed ID: 35483188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer's Disease.
    Reilly AM; Tsai AP; Lin PB; Ericsson AC; Oblak AL; Ren H
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice.
    Ou-Yang MH; Van Nostrand WE
    J Neuroinflammation; 2013 Nov; 10():134. PubMed ID: 24188129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
    Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons.
    Ishii M; Wang G; Racchumi G; Dyke JP; Iadecola C
    J Neurosci; 2014 Jul; 34(27):9096-106. PubMed ID: 24990930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
    Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
    J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model.
    Chen W; Huang Q; Lazdon EK; Gomes A; Wong M; Stephens E; Royal TG; Frenkel D; Cai W; Kahn CR
    Proc Natl Acad Sci U S A; 2023 May; 120(21):e2220684120. PubMed ID: 37186836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Robison LS; Gannon OJ; Salinero AE; Abi-Ghanem C; Kelly RD; Riccio DA; Mansour FM; Zuloaga KL
    Biol Sex Differ; 2023 Aug; 14(1):51. PubMed ID: 37559092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease.
    Robison LS; Gannon OJ; Thomas MA; Salinero AE; Abi-Ghanem C; Poitelon Y; Belin S; Zuloaga KL
    J Neuroinflammation; 2020 Sep; 17(1):285. PubMed ID: 32993686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.